tiprankstipranks
Avenue Therapeutics Inc (DE:49Y)
DUSSELDORF:49Y
Germany Market

Avenue Therapeutics (49Y) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

49Y Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Avenue
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

49Y Stock 12 Month Forecast

There Are No Analyst Ratings for DE:49Y In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

49Y Financial Forecast

49Y Earnings Forecast

The previous quarter’s earnings for 49Y were €0.09.
The previous quarter’s earnings for 49Y were €0.09.

49Y Sales Forecast

The previous quarter’s earnings for 49Y were €1.23M.
The previous quarter’s earnings for 49Y were €1.23M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - DeepSeek Analyst forecast on DE:49Y
TipRanks - DeepSeek
TipRanks - DeepSeek
€0.32€0.27
Hold
-32.96%
Downside
Reiterated
08/07/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on DE:49Y
TipRanks - xAI
TipRanks - xAI
€0.3€0.26
Hold
-35.78%
Downside
Reiterated
08/07/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on DE:49Y
TipRanks - Google
TipRanks - Google
€0.3€0.26
Hold
-36.21%
Downside
Reiterated
08/07/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on DE:49Y
TipRanks - OpenAI
TipRanks - OpenAI
€0.3€0.26
Hold
-35.78%
Downside
Reiterated
08/07/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on DE:49Y
TipRanks - PerPlexity
TipRanks - PerPlexity
€0.28€0.24
Sell
-40.12%
Downside
Downgraded
08/07/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on DE:49Y
TipRanks - Anthropic
TipRanks - Anthropic
€0.29€0.25
Sell
-38.16%
Downside
Reiterated
08/07/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
AI Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - DeepSeek Analyst forecast on DE:49Y
TipRanks - DeepSeek
TipRanks - DeepSeek
€0.32€0.27
Hold
-32.96%
Downside
Reiterated
08/07/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on DE:49Y
TipRanks - xAI
TipRanks - xAI
€0.3€0.26
Hold
-35.78%
Downside
Reiterated
08/07/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on DE:49Y
TipRanks - Google
TipRanks - Google
€0.3€0.26
Hold
-36.21%
Downside
Reiterated
08/07/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on DE:49Y
TipRanks - OpenAI
TipRanks - OpenAI
€0.3€0.26
Hold
-35.78%
Downside
Reiterated
08/07/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on DE:49Y
TipRanks - PerPlexity
TipRanks - PerPlexity
€0.28€0.24
Sell
-40.12%
Downside
Downgraded
08/07/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on DE:49Y
TipRanks - Anthropic
TipRanks - Anthropic
€0.29€0.25
Sell
-38.16%
Downside
Reiterated
08/07/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Avenue Therapeutics

3 Months
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate
1/1 ratings generated profit
100%
Average Return
+22.40%
Copying PerPlexity Biotechnology's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +22.40% per trade.
1 Year
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate
1/1 ratings generated profit
100%
Average Return
+22.40%
Copying PerPlexity Biotechnology's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +22.40% per trade.
2 Years
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate
1/1 ratings generated profit
100%
Average Return
+22.40%
Copying PerPlexity Biotechnology's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +22.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

49Y Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, 49Y has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 49Y average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

49Y Stock Forecast FAQ

What is DE:49Y’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:49Y’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:49Y, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Avenue Therapeutics Inc a Buy, Sell or Hold?
      Currently, no data Available
      What is Avenue Therapeutics Inc’s share price target?
      Currently, no data Available
      What do analysts say about Avenue Therapeutics Inc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Avenue Therapeutics Inc?
      To buy shares of DE:49Y, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.